Interferon-Gamma Mediated Immune Evasion: A Potential Mechanism of Resistance to Immunotherapy in Non-Small Cell Lung Cancer

被引：0
|
作者：
Zhou, H.
Li, F.
Yao, L.
Xie, D.
Li, Q.
Li, C.
Zhan, W.
机构：
[1] Guangdong Prov PeopleS Hosp, Dept Thorac Surg, Guangzhou, Peoples R China
[2] Guangdong Acad Med Sci, Guangzhou, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
non-small cell lung cancer; immunotherapy; Tumor immune microenvironment;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA03.07
引用
收藏
页码：S895 / S895
页数：1
相关论文
共 50 条
  • [1] Transformation to small cell lung cancer as a mechanism of resistance to immunotherapy in non-small cell lung cancer
    Bar, Jair
    Ofek, Efrat
    Barshack, Iris
    Gottfried, Teodor
    Zadok, Oranit
    Kamer, Iris
    Urban, Damien
    Perelman, Marina
    Onn, Amir
    LUNG CANCER, 2019, 138 : 109 - 115
  • [2] Small cell transformation as a mechanism of resistance to immunotherapy of non-small cell lung cancer
    Bar, Jair
    Urban, Damien
    Kuznetsov, Teodor
    Gadot, Moran
    Zadok, Oranit
    Kamer, Iris
    Perelman, Marina
    Onn, Amir
    Ofek, Efrat
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] IL-4 mediated TAP2 downregulation is a dominant and reversible mechanism of immune evasion and immunotherapy resistance in non-small cell lung cancer
    Ranjan, Kishu
    Rajendran, Barani Kumar
    Deen, Imad Ud
    Costantini, Adrien
    de Rodas, Miguel Lopez
    Desai, Shruti S.
    Scallo, Frankie
    Gianino, Nicole
    Ferrone, Soldano
    Schalper, Kurt A.
    MOLECULAR CANCER, 2025, 24 (01)
  • [4] TAP2 DEFICIENCY MEDIATES ADAPTIVE IMMUNE EVASION AND IMMUNOTHERAPY RESISTANCE IN HUMAN NON-SMALL CELL LUNG CANCER
    Ranjan, Kishu
    Deen, Imad Ud
    de Rodas, Miguel Lopez
    Gianino, Nicole
    Ferrone, Soldano
    Schalper, Kurt
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A161 - A161
  • [5] Biomarkers for immunotherapy resistance in non-small cell lung cancer
    Rother, Catriona
    John, Tom
    Wong, Annie
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [6] Interferon-gamma (INFG), a predictive factor of response to immune checkpoint blockade (ICB) in melanoma and non-small cell lung cancer (NSCLC)
    Gonzalez-Cao, Maria
    Karachaliou, Niki
    Crespo, Guillermo
    Aldeguer, Erika
    Drozdowskyj, Ana
    Gimenez-Capitan, Ana
    Teixido, Cristina
    Angel Molina-Vila, Miguel
    Viteri Ramirez, Santiago
    Martin Algarra, Salvador
    Perez-Ruiz, Elisabeth
    Marquez-Rodas, Ivan
    Rodriguez-Abreu, Delvys
    Blanco, Remei
    Puertolas, Teresa
    Angeles Royo, Maria
    Rosell, Rafael
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [7] Immunotherapy for Non-Small Cell Lung Cancer
    Yoon, Sung Ho
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2014, 77 (03) : 111 - 115
  • [8] Immunotherapy for non-small cell lung cancer
    Vafadar, Sam
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (09): : 37 - 42
  • [9] Immunotherapy in non-small cell lung cancer
    Peters, Geoffrey
    John, Thomas
    CANCER FORUM, 2018, 42 (01) : 24 - 28
  • [10] Immunotherapy for non-small cell lung cancer
    Kagamu, Hiroshi
    RESPIRATORY INVESTIGATION, 2024, 62 (02) : 307 - 312
12345